Holders — by stockHoldings — by fund
BALANCE CAPITAL PARTNERS L.P.
Everything this manager disclosed owning in US-listed stocks — its complete Form 13F portfolio · as of 2026-06-30 · filed with the SEC up to 45 days after quarter end · CIK 0002109256
$139.3M
disclosed book value
10
positions
70%
largest position share
Positions, as of 2026-06-30
top 10 of 10 · 13F covers long US-listed positions only — cash, bonds, private and foreign stakes are not disclosed · PUT/CALL tags = options positions (share-equivalents), not shares held
| # | Issuer | Shares | Value | % of book |
|---|---|---|---|---|
| 1 | PRMPERIMETER SOLUTIONS INC | 2.7M | $97.5M | 70% |
| 2 | XBISPDR SERIES TRUST | 64,000 | $10.1M | 7.3% |
| 3 | RHLDRESOLUTE HLDGS MGMT INC | 64,526 | $9.3M | 6.7% |
| 4 | TSMTAIWAN SEMICONDUCTOR MANUFAC | 11,000 | $5.3M | 3.8% |
| 5 | BLTEBELITE BIO INC | 22,500 | $3.5M | 2.5% |
| 6 | CPNGCOUPANG INC | 196,897 | $3.4M | 2.5% |
| 7 | SNSHARKNINJA INC | 20,504 | $3.1M | 2.2% |
| 8 | MRVLMARVELL TECHNOLOGY INC | 9,000 | $2.7M | 1.9% |
| 9 | TTMITTM TECHNOLOGIES INC | 13,000 | $2.4M | 1.7% |
| 10 | DNAGINKGO BIOWORKS HOLDINGS INC | 199,009 | $2.0M | 1.4% |
Source: SEC Form 13F-HR, reporting period 2026-06-30. Values are the manager's filed June-30-style quarter-end marks, not live prices. Research, not investment advice.